LIGAND PHARMA-TR BETA CVR (LGNZZ:OTCMKTS)
$0.073 0.0008 (1.108%)
Analysed LIGAND PHARMA-TR BETA CVR (LGNZZ:OTCMKTS) News Sources
Ligand Partner Travere Therapeutics Receives Full FDA Approval for FILSPARI® (sparsentan) in FSGS
14-04-2026
yahoo.com
Stock Market Today, April 6: Soleno Therapeutics Climbs After $2.9 Billion All-Cash Buyout Agreement
06-04-2026
fool.com
Is Ligand Pharmaceuticals (LGND) Still Attractive After Doubling Over The Past Year
04-04-2026
yahoo.com
CLO Sells LGND 5,000 Shares for $1.0 Million
31-03-2026
fool.com
Ligand Pharma CFO Sells $688K in Stock as Shares Surge 80% This Past Year. Here's What to Know
27-03-2026
fool.com
Ligand Advances Strategic Growth with Expanded and Strengthened Business Development Team
26-03-2026
yahoo.com
Two Biotech Stocks Hover Near Highs; Natural Gas And Finance Names Show Resilience
20-03-2026
yahoo.com
Assessing Ligand Pharmaceuticals (LGND) Valuation After Bank Of America’s New Buy Rating
13-03-2026
yahoo.com
How A Broad Sell-Off Rattled Top 3% Breakout Stock Ligand Pharma
12-03-2026
yahoo.com
Orchestra BioMed Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
12-03-2026
yahoo.com
What is the current price of LIGAND PHARMA-TR BETA CVR (LGNZZ:OTCMKTS)?
The current price of LIGAND PHARMA-TR BETA CVR (LGNZZ:OTCMKTS) is $0.073.
LIGAND PHARMA-TR BETA CVR (LGNZZ:OTCMKTS) absolute price change since previous trading day?
The absolute price change of LIGAND PHARMA-TR BETA CVR (LGNZZ:OTCMKTS) since the previous trading day is $0.0008.
LIGAND PHARMA-TR BETA CVR (LGNZZ:OTCMKTS) percentage price change since previous trading day?
The percentage price change of LIGAND PHARMA-TR BETA CVR (LGNZZ:OTCMKTS) since the previous trading day is 1.108%.
What is the most recent average sentiment score for LIGAND PHARMA-TR BETA CVR (LGNZZ:OTCMKTS)?
The most recent average sentiment score for LIGAND PHARMA-TR BETA CVR (LGNZZ:OTCMKTS) is 85 out of 100.
What is the most recent average sentiment for LIGAND PHARMA-TR BETA CVR (LGNZZ:OTCMKTS)?
The most recent sentiment for LIGAND PHARMA-TR BETA CVR (LGNZZ:OTCMKTS) is .
SEC-8K** Filing Available For LIGAND PHARMA-TR BETA CVR (LGNZZ:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.